A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 21, 2018

Primary Completion Date

November 23, 2018

Study Completion Date

November 23, 2018

Conditions

Healthy Females

Interventions

DRUG

PF-06651600

200 mg by mouth (PO) Once daily (QD) for 11 days

DRUG

Ethinyl estradiol (EE) and levonogestrel (LN)

Single dose of Oral tablet containing 30 ug EE and 150 ug of LN

Trial Locations (2)

Quotient Sciences-Miami, Inc., Miami

Quotient Sciences, Coral Gables